Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
摘要:
Measurement of human urinary carcinogen metabolites is a practical approach for obtaining important information about tobacco and cancer. This review presents currently available methods and evaluates their utility. Carcinogens and their metabolites and related compounds that have been quantified in the urine of smokers or non-smokers exposed to environmental tobacco smoke (ETS) include trans,trans-muconic acid (tt-MA) and S-phenylmercapturic acid (metabolites of benzene), 1- and 2-naphthol, hydroxyphenanthrenes and phenanthrene dihydrodiols, 1-hydroxypyrene (1-HOP), metabolites of benzo[a]pyrene, aromatic amines and heterocyclic aromatic amines, N-nitrosoproline, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides (NNAL and NNAL-Gluc), 8-oxodeoxyguanosine, thioethers, mercapturic acids, and alkyladenines. Nitrosamines and their metabolites have also been quantified in the urine of smokeless tobacco users. The utility of these assays to provide information about carcinogen dose, delineation of exposed vs. non-exposed individuals, and carcinogen metabolism in humans is discussed. NNAL and NNAL-Gluc are exceptionally useful biomarkers because they are derived from a carcinogen- 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)- that is specific to tobacco products. The NNAL assay has high sensitivity and specificity, which are particularly important for studies on ETS exposure. Other useful assays that have been widely applied involve quantitation of 1-HOP and tt-MA. Urinary carcinogen metabolite biomarkers will be critical components of future studies on tobacco and human cancer, particularly with respect to new tobacco products and strategies for harm reduction, the role of metabolic polymorphisms in cancer, and further evaluation of human carcinogen exposure from ETS.
展开
关键词:
BaP, benzo[a]pyrene ETS, environmental tobacco smoke GC–TEA, gas chromatography with nitrosamine selective detection 1-HOP, 1-hydroxypyrene iso-NNAC, 4-(methylnitrosamino)-4-(3-pyridyl)butyric acid NMTCA, N-nitroso-2-methylthiazolidine 4-carboxylic acid NNAL, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol NNAL-Gluc, a mixture of 4-(methylnitrosamino)-1-(3-pyridyl)-1-(O-β-d-glucopyranuronosyl)butane(NNAL-O-Gluc) and 4-(methylnitrosamino)-1-(3-pyridyl-N-β-d-glucopyranuronosyl)-1-butanolonium inner salt (NNAL-N-Gluc) NPRO, N-nitrosoproline NSAR, N-nitrososarcosine NTCA, N-nitrosothiazolidine 4-carboxylic acid 8-oxo-dG, 8-oxodeoxyguanosine PAH, polycyclic aromatic hydrocarbons PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine PREPS, potential reduced-exposure products S-PMA, S-phenylmercapturic acid trans-anti-BaP-tetraol, r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene tt-MA, trans,trans-muconic acid.
DOI:
10.1093/carcin/23.6.907
被引量:



























通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!